Probiotic health benefits - Reality or myth?

Australian Journal of Dairy Technology

Volumn 58, Issue 2, 2003, Pages 107-113

  Stanton, C ^a   Desmond, C ^a,b   Fitzgerald, G ^b   Ross, R P ^a  

^a ANIMAL AND GRASSLAND RESEARCH AND INNOVATION CENTRE   (Ireland)

^b Department of Microbiology   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOLOGY; BIOMEDICAL ENGINEERING; LIPIDS; MEDICAL APPLICATIONS; MOLECULAR BIOLOGY; NUTRITION; TUMORS;

FUNCTIONAL FOOD MARKETS;

DAIRY PRODUCTS;

BACTERIA (MICROORGANISMS);

EID: 0141484350     PISSN: 00049433     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (81)

1. Coakley, M., Ross, R.P., Nordgren, M., Fitzgerald, G., Devery, R. and Stanton, C. (2003), Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species, J. Appl. Microbiol. 94(1), 138-45.
2. Collins, J.K., Thornton, G. and O'Sullivan, G.O. (1998), Selection of probiotic strains for human application, Int. Dairy J. 8, 487-490.
3. Cremonini, F., di Caro, S., Bartolozzi, F., Gasbarrini, G. and Gasbarrini, A. (2001), Use of probiotics in antibiotic-associated diarrhea: meta-analysis of placebo-controlled trials, Am. J. Gastroenterol. 96(9), 459.
4. Cross, M.L. (2002), Immunoregulation by probiotic lactobacilli: pro-Th1 signals and their relevance to human health, Clin. Appl. Immunol. Rev., 3, 115-125.
5. Cummings, J.H. and Macfarlane, G.T. (1991), The control and consequences of bacterial fermentation in the human colon, J. Appl. Bacterial. Jun, 70(6), 443-459.
6. de Vrese, M., Stegelmann, A., Richter, B., Fenselau, S., Laue, C. and Schrezenmeir, J. (2001), Probiotics - compensation for lactase insufficiency, Am. J. Clin. Nutr. Feb;73(2) Suppl, 421S-429S.
7. FAO/WHO (2001), Evaluation of health and nutritional properties of powder milk with live lactic acid bacteria, Report from FAO/WHO Expert consultation 1-4 Oct, Cordoba, Argentina.
8. FAO/WHO (2002), Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food, April 30 and May 1,.London, Ontario, Canada.
9. Fooks, L.J., Fuller, R. and Gibson, G.R. (1999), Prebiotics, probiotics and human gut microbiology, Int. Dairy J. 9(1), 53-61.
10. Fuller, R. (1989), Probiotics in man and animals, J. Appl. Bacterial. May, 66(5), 365-378.
11. Fuller, R. (1992), History and development of probiotics. In Probiotics - The Scientific Basis (Ed. R. Fuller). Chapman and Hall, New York, Chap. 1.
12. Gibson, G.R. and Roberfroid, M.B. (1995), Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics, J. Nutr. 125, 1401-1412.
13. Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K.M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M. and Campieri, M. (2003), Prohylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial, Gastroenterol. May, 124(5), 1202-1209.
14. Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M. and Campieri, M. (2000a), Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterol. August, 119(2), 305-309.
15. Gionchetti, P., Rizzello, F., Venturi, A. and Campieri, M. (2000b), Probiotics in infective diarrhoea and inflammatory bowel diseases, J. Gastroenterol. Hepatol. May, 15(5), 489-493.
16. Goldin, B.R., Gualtieri, L.J. and Moore, R.P. (1996), The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat, Nutr. Cancer. 25(2), 197-204.
17. Gorbach, S.L. (2002), Probiotics in the third millennium, Dig. Liver Dis. Sep, 34 Suppl 2, S2-S7.
18. Guandalini, S., Pensabene, L., Zikri, M.A., Dias, J.A., Casali, L.G., Hoekstra, H., Kolacek, S., Massar, K., Micetic-Turk, D., Papadopoulou, A., de Sousa, J.S., Sandhu, B., Szajewska, H. and Weizman, Z. (2000), Lactobacillus GG administered in oral rehydration solution to children with acute diarrhoeahea: a multicenter European trial, J. Pediatr. Gastroenterol. Nutr. Jan, 30(1), 54-60.
19. Guarino, A., Canani, R.B., Spagnuolo, M.I., Albano, F. and Di Benedetto, L. (1997), Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea, J. Pediatr. Gastroenterol. Nutr. Nov, 25(5), 516-519.
20. Haberer, P., du Toit, M., Dicks, L.M.T., Ahrens, F. and Holzapfel, W.H. (2003), Effect of potentially probiotic lactobacilli on faecal enzyme activity in minipigs on a high-fat, high-cholesterol diet - a preliminary in vivo trial, Int. J. Food Micro. 2727, 1-5.
21. Havenaar, R. and Huis in't Veld, J.H.J., (1992), Probiotics:. A general view. In The Lactic Acid Bacteria: The Lactic Acid Bacteria in Health and Disease, Vol. 1 (Ed. B.J.B. Wood). Chapman and Hall, New York, 209-248.
22. Hertzler, S.R. and Savaiano, D. (1996), Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance, Am. J. Clin. Nutr. Aug, 64(2), 232-236.
23. Hove, H., Nordgard-Andersen, M. and Mortensen, P.B. (1994), Effect of lactic acid bacteria on the intestinal production of lactate and short chain fatty acids, and the absorption of lactose, Am. J. Clin. Nutr. 59, 74-79.
24. Hughes, D.B. and Hoover, D.G. (1991), Bifidobacteria: their potential for use in American dairy products, Fd. Technol. 45, 74-83.
25. Ishibashi, N. and Shimamura, S. (1993), Bifidobacteria: research and development in Japan, Fd. Technol. 46, 126-135.
26. Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P. and Koivula, T. (1991), A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children, Pediatrics. Jul, 88(1), 90-97.
27. Isolauri, E., Salminen, S. and Mattila-Sandholm, T. (1999), New functional foods in the treatment of food allergy, Ann. Med. Aug, 31(4), 299-302.
28. Jiang, T., Mustapha, A., and Savaiano, D.A. (1996), Improvement of lactose digestion by ingestion of unfermented milk containing Bifidobacterium longum, J. Dairy Sci. 79, 750-757.
29. Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E. (2001), Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial, Lancet. 357, 1076-79.
30. Kankaanpaa, P.E., Yang, B., Kallio, H.P., Isolauri, E. and Salminen, S.J. (2002), Influence of probiotic supplemented infant formula on the composition of plasma lipids in atopic infants, J. Nutr. Biochem. 13, 364-369.
31. Kimura, K., McCartney, A.L., McConnell., M.A. and Tannock, G.W. (1997), Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains, Appl. Environ. Microbiol. 63, 3394-3398.
32. Kirjavainen, P.V., Apostolou, E., Arvola, T., Salminen, S.J., Gibson, G.R. and Isolauri, E. (2001), Characterising the composition of intestinal microflora as a prospective treatment target in infant allergic disease, FEMS Immunol. Med. Micro. 32, 1-7.
33. Kolars, J., Levitt, M. Aouji, M. and Savaiano, D. (1984), Yoghurt - an autodigesting source of lactose, N. Engl. J. Med. 310, 1-3.
34. Kopeloff, N. (1926) Lactobacillus Acidophilus. Williams and Wilkins Co., Baltimore,MD.
35. Kopp-Hoolihan L. (2001), Prophylactic and therapeutic uses of probiotics: A Review. J. Amer. Diet. Assoc. Feb, 101(2), 229-241.
36. Leatherhead Food Research Association (2000), Functional Food Markets, Innovation and Prospects, http://www.leatherheadfood.com/lfi/pdf/ffinnovprosp.pdf
37. Lee, Y.K. and Salminen, S. (1995), The coming of age of probiotics, Trends Fd. Sci. Tech. 6, 241-245.
38. Lin, M.Y., Savaiani, D. and Harlander, S. (1991), Influence of nonfermemed dairy products containing bacterial starter cultures on lactose maldigestion in humans, J. Dairy Sci. Jan, 74(1), 87-95.
39. Luckey, T.D. and M.H. Floch. (1972), Introduction to intestinal microecology, Amer. J. Clin. Nutr. 25, 1291-1295.
40. Macfarlane, G.T. and Gibson, G.R. (1994), Metabolic interactions between colonic bacteria and the host. In Human Health: The Contribution of Microorganisms (Ed. S.A.W. Gibson). Springer-Verlag, London, pp 17-52.
41. Majamaa, H., Isolauri, E., Saxelin, M. and Vesikari, T. (1995), Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis, J. Pediatr. Gastroenterol. Nutr. Apr, 20(3), 333-338.
42. Malin, M., Suomalainen, H., Saxelin, M. and Isolauri, E. (1996), Promotion of IgaA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG, Ann Nutr Metab. 40, 137-145.
43. Marteau P., Messing B., Arrigoni, E., Briet, F., Flourie, B., Morin, M.C. and Rambaud, J.C. (1997), Do patients with short-bowel syndrome need a lactose-free diet, Nut. Jan, 13(1), 13-26.
44. Marteau, P. Seksik, P. and Jian, R. (2002), Probiotics and health: new facts and ideas, Curr. Opin. Biotech. October, 13(5), 486-489.
45. Marteau, P. Seksik, P. and Shanahan, F. (2003), Manipulation of the bacterial flora in inflammatory bowel disease, Best Prac. Res. Clin. Gasroenterol. February, 17(1), 47-61.
46. Martini, M.C., Lerebours, E.C., Lin, W. and Harlander, S.K. (1991), Strains and species of lactic acid bacteria in fermented milks (yoghurts): effect on in vivo lactose digestion, Am. J. Clin. Nutr. 54, 1041-1046.
47. Matsuzaki, T. and Chin J. (2000), Modulating immune responses with probiotic bacteria, Immunol Cell Biol. Feb, 78(1), 67-73.
48. McCartney, A.L., Wenzhi, W. and Tannock, G.W. (1996), Molecular analysis of the composition of the bifidobacterial and Lactobacillus microflora of humans, Appl. Environ. Microbiol. 62, 4608-4613.
49. McNaught, C.E. and MacFie, J. (2001), Probiotics in clinical practice: a critical review of the evidence, Nut. Res. January-February, 21(1-2), 343-353.
50. Mitsuoka, T. (1992a), Intestinal flora and ageing, Nutr. Rev. 50, 438-446.
51. Mitsuoka, T. (1992b), The human gastrointestinal tract. In The Lactic Acid Bacteria (Ed. B.J.B. Wood). Elsevier Appl. Sci., New York, pp 69-114.
52. Mitsuyama, K., Toyonaga, A. and Sata, M. (2002), Intestinal microflora as a therapeutic target in inflammatory bowel disease, J. Gastroenterol. Nov, 37, Suppl 14, 73-77.
53. Moore, W.E. and Moore L.H. (1995), Intestinal floras of populations that have a high risk of colon cancer, Appl. Environ. Microbiol. September, 61(9), 3202-3207.
54. Naidu, A.S., Biblack, W.R. and Clemens, R.A. (1999), Probiotic spectra of lactic acid bacteria (LAB), Crit. Revs. Fd. Sci. Nutr. 39, 13-16.
55. O'Sullivan, D.J. and Kullen, M.J. (1998), Tracking of probiotic bifidobacteria in the intestine, Int. Dairy J. 8, 513-525.
56. Ouwehand, A.C., Kirjavainen, P.V., Shortt, C. and Salminen, S. (1999), Probiotics: mechanisms and established effects, Int. Dairy J. 9, 43-52.
57. Ouwehand A.C., Salminen S. Isolauri E. (2002), Probiotics: an overview of beneficial effects, Ant. Van Leeuwen. Aug, 82(1-4), 279-289.
58. Pereira, D.I. and Gibson, G.R. (2002), Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut, Appl. Environ. Microbiol., Sep, 68(9), 4689-93.
59. Rao, C.V., Sanders, M.E., Indranie, C., Simi, B. and Reddy, B.S. (1999), Prevention of colonic preneoplastic lesions by the probiotic Lactobacillus acidophilus NCFMTM in F344 rats, Int. J. Oncol. May, 14(5), 939-944.
60. Reid, G. and Burton J. (2002), Use of Lactobacillus to prevent infection by pathogenic bacteria, Micro. Infect. 4, 319-324.
61. Rosenfeldt, V., Benfeldt, E, Nielsen, S.D., Michaelsen, K.F., Jeppesen, D.L., Valerius, N.H. and Paerregaard, A. (2003), Effect of probiotic Lactobacillus strains in children with atopic dermatitis, J. Allerg. Clin. Immunol. February, 111(2), 390-395.
62. Saavedra, J.M., Bauman, N.A., Oung, I., Perman, J.A. and Yolken, R.H. (1994), Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus, Lancet, Oct 15, 344(8929), 1046-1049.
63. Salminen, S., Ouwenhand, A., Benno, Y. and Lee, Y. K. (1999), Probiotics: how should they be defined? Trends Fd. Sci. Tech. 10, 107-110.
64. Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., Fonden, R., Saxelin, M., Collins, K., Mogensen, G., Birkeland, S.E. and Mattila-Sandholm, T. (1998), Demonstration of safety of probiotics - a review, Int. J. Food Microbiol. Oct 20, 44(1-2), 93-106.
65. Sanders, M.E. (1993), Summary of conclusions from a consensus panel of experts on health attributes of lactic cultures: significance to fluid milk products containing cultures, J. Dairy Sci. Jul, 76(7), 1819-1828.
66. Sanders, M.E. and Huis in't Veld, J. (1999), Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labelling issues, Anton. Leeuw. Int. J. C. 76, 293-315.
67. Scrimshaw, N.S. and Murray, E.B. (1988), The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance, Am J Clin Nutr. Oct, 48(4) Suppl., 1079-1159.
68. Shanahan, F. (2000), Immunology. Therapeutic manipulation of gut flora, Science. Aug, 289(5483), 1311-1322.
69. Shanahan, F. O'Sullivan, G.C. and Collins, J.K. (1998), Genes, bacteria and T cells: ingredients for inflammatory bowel disease, Gastroenterol. 115, 1595-1600.
70. Shornikova, A.V, Casas, I.A., Isolauri, E., Mykkanen, H. and Vesikari, T. (1997), Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children, J. Pediatr. Gastroenterol. Nutr. Apr, 24(4), 399-404.
71. Spanhaak, S., Havenaar, R. and Schaafsma, G. (1998), The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans, Eur. J. Clin. Nutr. Dec, 52(12), 899-907.
72. Stanton, C., Desmond, C., Coakley, M., Collins, J.K., Fitzgerald, G. and Ross, R.P. (2003), Challenges Facing Development of Probiotic-Containing Functional Foods. In Fermented Foods (Ed. E. Farnworth). CRC Press, Florida, Chap 11.
73. Stanton, C., Gardiner, G., Meehan, H., Collins, K., Fitzgerald, G., Lynch, P.B. and Ross, R.P. (2001), Market potential for probiotics, Am. J. Clin. Nutr. 73, 476S-483S.
74. Sullivan, A. and Nord, C.E. (2002), The place of probiotics in human intestinal infections, Int. J. Antinmicro. Ag. 20, 313-319.
75. Szajewska, H. Kotowska, M., Mrukowicz, J.Z., Armanska, M. and Mikolajczyk, W. (2001), Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants, J Pediatr. Mar. 138(3), 361-365.
76. Tannock, G.W. (2001), Molecular assessment of intestinal microflora, Am. J. Clin. Nutr. Feb, 73(2 Suppl), 410S-414S.
77. Thomas, R.M., Litin, S. C., Osmon, D.R., Corr, A.P., Weaver, A.L. and Lohse, C.M. (2001) Lack of effect of Lactobacillus GG on antibiotic associated diarrhoea: a randomised, placebo-controlled trial, Mayo Clin. Proc. 76, 883-889.
78. Tissier, H. (1906), Traitement des infections intestinales par la méthode de la flore bactérienne de l'Intestin, C.R. Soc. Biol 60, 359-361.
79. Van Niel, C.W., Feudtner, C., Garrison, M.M. and Christakis, D.A. (2002), Lactobacillus therapy for acute infectious diarrhea in children: meta-analysis, Pediatrics. April, 109(4), 678-684.
80. Wollowski, I., Rechkemmer, G. and Pool-Zobel, B.L. (2001), Protective role of probiotics and prebiotics in colon cancer, Am. J. Clin. Nut., Suppl. 73(2), 451S-455S.
81. Ziemer, C. and Gibson, G.R. (1998), An overview of probiotics, prebiotics and synbiotics in the functional food concept: perspectives and future strategies, Int. Dairy J. 8, 473-479.